This webinar provided an update on developments in the field relating to content presented at the Advances in Cancer Immunotherapy programs and focused on applicable information for a clinical audience. More specifically, program organizers Christian M. Capitini, MD, and Zachary S. Morris,...
The ASCO-SITC Clinical Immuno-Oncology Symposium is a three-day meeting focused on clinical and translational research in immuno-oncology and the implications for clinical care. This meeting addresses the high-level of need for clinical education in a field where all aspects of care are...
02-28-2019 07:30 - 03-02-2019 16:00 PT San Francisco CA
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article the PARP inhibitor olaparib was combined with durvalumab to treat mCRPC, regardless of patients’ mutational status. Authors: Fatima Karzai , David VanderWeele , Ravi A. Madan , Helen Owens , Lisa M. Cordes ...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is an update on long-term survival results from two single-arm, phase II adjuvant trials (Trial 3 and Trial 5) with the focus on treatment beyond recurrence of the disease. Authors: Jacek Mackiewicz , Tomasz Burzykowski , Dariusz...
Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article that reports the evaluation of a next generation STAT3 ASO (AZD9150) in a non-Hodgkin’s lymphoma population, primarily consisting of patients with DLBCL. Authors: Matthew J. Reilley , Patricia McCoon , Carl...
Presented by the Spanish Group for Immuno-Biological Therapies in Cancer (GÉTICA) in collaboration with the Society for Immunotherapy of Cancer (SITC). FIT-Cancer V is an educational program focused on facilitating the exchange of knowledge between immunologists and clinicians, to enable...
03-07-2019 00:00 - 03-09-2019 23:55 CET Madrid
The 11th Breast, Gynecological and Immuno-oncology International Cancer Conference (BGIICC) is the only conference specialized in breast gynecological cancers in Africa and the Middle-East. The 2019 Scientific Program is designed to give a good platform for the exchange of experience on cancers...
01-17-2019 00:00 - 01-18-2019 23:55 EET Cairo Governorate
Presented by The University of Texas MD Anderson Cancer Center and Creative Educational Concepts, Inc. (CEC) in collaboration with the Society for Immunotherapy of Cancer. This program is ideally suited for North American-based Junior Faculty, Fellows, and Postdoctoral Researchers (MDs, DOs,...
04-25-2019 08:00 - 04-27-2019 20:00 CT Houston TX
Published in the Journal for ImmunoTherapy of Cancer, is a research article about 3-year outcomes from the open-label, parallel-cohort, dose-escalation, phase I CheckMate 016 study of patients with aRCC treated with a combination of nivolumab and the TKIs sunitinib or pazopanib. Authors: Asim...
Learn more about immunotherapy and targeted therapies for the treatment of lung cancer, and hear from lung cancer survivors on LUNGevity's video library. Click here to explore LUNGevity's video library. #ClinicalTrials #Biomarkers #LungCancers #Non-SmallCellLungCancer #Small...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us